News

Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Tool

From PCOS to PMOS: What a Name Change Can and Can’t Do

Factory Capital Commits $18M to Build Women’s Midlife Health Into an Institutional Investment Category

Aspira Women’s Health and Cleveland Clinic Expand Collaboration on AI-Powered Diagnostics for Ovarian Cancer and Endometriosis

GenoPalate and Mamaya Health Partner to Connect Personalized Nutrition with Women’s Mental Health Care

Noom Launches At-Home Biomarker Test Kit Including Hormonal and Metabolic Markers

Gaia Secures $100M Debt Facility to Scale Outcome-Protected Fertility Financing

New Paper Proposes Four-Pillar Framework for Aligning Femtech Innovation with Health Equity

Inception Fertility Launches MySpermBank, Adding Donor Sperm Platform to Its Fertility Network

Oli Raises $6.5M to Advance Predictive Maternal and Fetal Monitoring Ahead of Market Entry

Oura Files Confidentially for IPO

FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years

Evvy Launches AI Advisor for Vaginal Health Built on 100,000+ Microbiome Tests

Cyclana Bio Recruits First Patients in UK Endometriosis Study

Nourish Raises $100M Series C for AI-Native Metabolic Health Clinic With GLP-1 Integration

FDA Approves ENHERTU for Early Breast Cancer in Two New Indications

Why Investors Are Betting Big on Incontinence

Australian Medtech NinaMED Launches with $13.75M to Develop Non-Invasive Wearable for Overactive Bladder

Inside SPRIND’s Push to Build a Continuous Hormone Monitoring Industry in Europe

BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence

Maipl Therapeutics Advances Non-Hormonal Oral Endometriosis Therapy Targeting Prostaglandin F2α Receptor

UroMems Raises $60M for Smart Implant to Treat Stress Urinary Incontinence

Autoimmunity BioSolutions Closes $1M Seed Extension for Genetically Targeted Autoimmune Therapy

The Cost Problem: Who Actually Gets to Benefit From Women’s Health Innovation?